Clinical trials
Phase 3 Hemorrhagic Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioMarin Pharmaceutical | 3 |
| Genzyme, a Sanofi Company | 2 |
| Takeda | 2 |
| Baxalta now part of Shire | 1 |
| CTI BioPharma | 1 |
| Cangene Corporation | 1 |
| Kedrion S.p.A. | 1 |
| Swedish Orphan Biovitrum | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 12 |
| Hemorrhagic Disorders | 12 |
| Blood Coagulation Disorders | 8 |
| Coagulation Protein Disorders | 7 |
| Hemophilia A | 7 |
| Blood Coagulation Disorders, Inherited | 6 |
| Genetic Diseases, Inborn | 6 |
| Autoimmune Diseases | 3 |
| Blood Platelet Disorders | 3 |
| Genetic Diseases, X-Linked | 3 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.